Clinical Trial

Reliability and Validity of the Turkish Version of the SCIPI

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated June 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
Pain after spinal cord injury (SCI) is common, with the majority of individuals experiencing chronic pain and a significant portion reporting severe pain that interferes with their daily lives. Pain due to SCI is divided into two main groups: nociceptive and neuropathic. Clinical expertise is required for the accurate classification of these types of pain. Existing screening tools are generally evaluated with heterogeneous samples and therefore have limited accuracy in individuals with SCI. To address this deficiency, the Spinal Cord Injury Pain Instrument (SCIPI) was developed to define neuropathic pain in a manner specific to SCI. The SCIPI consists of seven items that assess the characteristics of pain and triggering factors. Although this scale, developed in English, has been translated into different languages, there is no Turkish version. This study aimed to examine the validity and reliability of the Turkish version of the SCIPI.
Trial Details
NCT Number NCT06990243
Lead Sponsor Istinye University
Conditions Neuropathic Pain, Spinal Cord Injury
Enrollment 40 participants
Start Date 2025-05-28
Primary Completion 2025-06-28 (estimated)
Study Completion 2025-07-28 (estimated)
Updated on ClinicalTrials.gov 2025-05-25